Hemasure, Inc.

I.d.m. Immuno-designed Molecules

Yves Fouron

Charles M Zepp

Eric K Lee

Franco Castino

Jacques Bartholeyns

Jean-Loup Romet-Lemonne

Abdul R Azad

The present invention relates to combined preparation containing as active substance the following individual components, in the form of a kit-of-parts: monocyte derived cells, particularly cytotoxic macrophages, chemotherapy or immunotherapy drugs, for the simultaneous, separate or sequential use, for the treatment of cancer or infectious diseases.

Combined preparation for the treatment of neoplasic diseases or of infectious diseases

Filter devices for simultaneously removing leukocytes and viral inactivating agents from whole blood or blood fractions are disclosed. One type of device comprises (1) a housing surrounding (2) activated carbon and (3) a mechanically stable polymeric material which may optionally be modified to attach a ligand for leukocytes. General methods for removing leukocytes and viral inactivating agents from blood and plasma are also disclosed.

Method for removing leukocytes and methylene blue from plasma

Device for simultaneously removing leukocytes and methylene blue from

Process for simultaneously removing leukocytes and methylene blue from

Filter devices for simultaneously removing leukocytes and methylene blue from whole blood or blood fractions are disclosed. One type of device comprises (1) a housing surrounding (2) activated carbon and (3) a mechanically stable polymeric material which may optionally be modified to attach a ligand for leukocytes. General methods for removing leukocytes and methylene blue from blood and plasma are also disclosed.

Growing community of inventors

Marlborough, MA, United States of America

Yves Fouron